These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 17939909)

  • 1. [Trends in prognostic factors for neuroendocrine lung tumors].
    García-Yuste M; Molins L; Matilla JM; González-Aragoneses F; López-Pujol J; Ramos G; de la Torre M;
    Arch Bronconeumol; 2007 Oct; 43(10):549-56. PubMed ID: 17939909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors in neuroendocrine lung tumors: a Spanish Multicenter Study. Spanish Multicenter Study of Neuroendocrine Tumors of the Lung of the Spanish Society of Pneumonology and Thoracic Surgery (EMETNE-SEPAR).
    García-Yuste M; Matilla JM; Alvarez-Gago T; Duque JL; Heras F; Cerezal LJ; Ramos G
    Ann Thorac Surg; 2000 Jul; 70(1):258-63. PubMed ID: 10921719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pulmonary neuroendocrine tumors. The spectrum of histologic subtypes and current concept on diagnosis and treatment].
    Langfort R; Rudziński P; Burakowska B
    Pneumonol Alergol Pol; 2010; 78(1):33-46. PubMed ID: 20162517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
    Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
    Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Typical and atypical pulmonary carcinoids : outcome in patients presenting with regional lymph node involvement.
    Thomas CF; Tazelaar HD; Jett JR
    Chest; 2001 Apr; 119(4):1143-50. PubMed ID: 11296182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pulmonary carcinoid: analysis of a single institutional experience and prognostic factors].
    Correia Sda S; Pinto C; Bernardo J
    Acta Med Port; 2014; 27(6):749-54. PubMed ID: 25641291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Typical and atypical carcinoid tumours: analysis of the experience of the Spanish Multi-centric Study of Neuroendocrine Tumours of the Lung.
    García-Yuste M; Matilla JM; Cueto A; Paniagua JM; Ramos G; Cañizares MA; Muguruza I;
    Eur J Cardiothorac Surg; 2007 Feb; 31(2):192-7. PubMed ID: 17196822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuroendocrine tumors of the lung].
    Oliaro A; Donati G; Filosso PL; Ruffini E
    Minerva Chir; 2000; 55(1-2):7-16. PubMed ID: 10832278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reclassification of neuroendocrine tumors improves the separation of carcinoids and the prediction of survival.
    Skov BG; Krasnik M; Lantuejoul S; Skov T; Brambilla E
    J Thorac Oncol; 2008 Dec; 3(12):1410-5. PubMed ID: 19057265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors in neuroendocrine tumours of the lung: a single-centre experience.
    Filosso PL; Ruffini E; Di Gangi S; Guerrera F; Bora G; Ciccone G; Galassi C; Solidoro P; Lyberis P; Oliaro A; Sandri A
    Eur J Cardiothorac Surg; 2014 Mar; 45(3):521-6; discussion 526. PubMed ID: 24092506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in TNM staging of pulmonary neuroendocrine tumors requires histology and regrouping of tumor size.
    Cattoni M; Vallières E; Brown LM; Sarkeshik AA; Margaritora S; Siciliani A; Filosso PL; Guerrera F; Imperatori A; Rotolo N; Farjah F; Wandell G; Costas K; Mann C; Hubka M; Kaplan S; Farivar AS; Aye RW; Louie BE
    J Thorac Cardiovasc Surg; 2018 Jan; 155(1):405-413. PubMed ID: 28986041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine Tumors of the Lung: Updates and Diagnostic Pitfalls.
    Hung YP
    Surg Pathol Clin; 2019 Dec; 12(4):1055-1071. PubMed ID: 31672294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staging System for Neuroendocrine Tumors of the Lung Needs to Incorporate Histologic Grade.
    Jackson AS; Rosenthal A; Cattoni M; Bograd AJ; Farivar AS; Aye RW; Vallières E; Louie BE
    Ann Thorac Surg; 2020 Apr; 109(4):1009-1018. PubMed ID: 31706866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic and diagnostic value of epithelial to mesenchymal transition markers in pulmonary neuroendocrine tumors.
    Galván JA; Astudillo A; Vallina A; Crespo G; Folgueras MV; González MV
    BMC Cancer; 2014 Nov; 14():855. PubMed ID: 25413006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine neoplasms of the lung: a prognostic spectrum.
    Asamura H; Kameya T; Matsuno Y; Noguchi M; Tada H; Ishikawa Y; Yokose T; Jiang SX; Inoue T; Nakagawa K; Tajima K; Nagai K
    J Clin Oncol; 2006 Jan; 24(1):70-6. PubMed ID: 16382115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The IASLC Lung Cancer Staging Project: proposals for the inclusion of broncho-pulmonary carcinoid tumors in the forthcoming (seventh) edition of the TNM Classification for Lung Cancer.
    Travis WD; Giroux DJ; Chansky K; Crowley J; Asamura H; Brambilla E; Jett J; Kennedy C; Rami-Porta R; Rusch VW; Goldstraw P;
    J Thorac Oncol; 2008 Nov; 3(11):1213-23. PubMed ID: 18978555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution and Characteristics of Pulmonary Neuroendocrine Tumors: Single Institution Experience in Lebanon.
    Kesrouani C; Ghorra C; Rassy M; Kourie HR; Kattan J
    Asian Pac J Cancer Prev; 2016; 17(5):2579-81. PubMed ID: 27268633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary large cell carcinomas with neuroendocrine features are high-grade neuroendocrine tumors.
    Iyoda A; Hiroshima K; Baba M; Saitoh Y; Ohwada H; Fujisawa T
    Ann Thorac Surg; 2002 Apr; 73(4):1049-54. PubMed ID: 11996239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERCC1 and Ki67 in small cell lung carcinoma and other neuroendocrine tumors of the lung: distribution and impact on survival.
    Skov BG; Holm B; Erreboe A; Skov T; Mellemgaard A
    J Thorac Oncol; 2010 Apr; 5(4):453-9. PubMed ID: 20104194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular markers help characterize neuroendocrine lung tumors.
    Rusch VW; Klimstra DS; Venkatraman ES
    Ann Thorac Surg; 1996 Sep; 62(3):798-809; discussion 809-10. PubMed ID: 8784011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.